Open AccessSustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
Author(s) -
Naggie Susanna,
Ramers Christian B.
Publication year - 2019
Publication title -
hepatology communications
Language(s) - English
Resource type - Journals
ISSN - 2471-254X
DOI - 10.1002/hep4.1347
Subject(s) - medicine , harm reduction , opioid epidemic , hepatitis c , ribavirin , population , human immunodeficiency virus (hiv) , pegylated interferon , family medicine , hepatitis c virus , intensive care medicine , virology , opioid , environmental health , virus , receptor
Editorial in response to “Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy”